NDC 0135-0096 Gaviscon Regular Strength
Aluminum Hydroxide And Magnesium Trisilicate Tablet, Chewable Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
Product Characteristics
CHERRY (C73375)
Code Structure Chart
Product Details
What is NDC 0135-0096?
What are the uses for Gaviscon Regular Strength?
What are Gaviscon Regular Strength Active Ingredients?
- ALUMINUM HYDROXIDE 80 mg/1 - A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc.
- MAGNESIUM TRISILICATE 14.2 mg/1
Which are Gaviscon Regular Strength UNII Codes?
The UNII codes for the active ingredients in this product are:
- ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
- ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) (Active Moiety)
- MAGNESIUM CARBONATE (UNII: 0E53J927NA)
- CARBONATE ION (UNII: 7UJQ5OPE7D) (Active Moiety)
- MAGNESIUM TRISILICATE (UNII: C2E1CI501T)
- MAGNESIUM CATION (UNII: T6V3LHY838) (Active Moiety)
Which are Gaviscon Regular Strength Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALGINIC ACID (UNII: 8C3Z4148WZ)
- CALCIUM STEARATE (UNII: 776XM7047L)
- SODIUM BICARBONATE (UNII: 8MDF5V39QO)
- SUCROSE (UNII: C151H8M554)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- SORBITOL (UNII: 506T60A25R)
- MANNITOL (UNII: 3OWL53L36A)
- STARCH, CORN (UNII: O8232NY3SJ)
- ACESULFAME POTASSIUM (UNII: 23OV73Q5G9)
- CORN SYRUP (UNII: 9G5L16BK6N)
What is the NDC to RxNorm Crosswalk for Gaviscon Regular Strength?
- RxCUI: 1086458 - Gavsicon Regular Strength 80 MG / 14.2 MG Chewable Tablet
- RxCUI: 1086458 - aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG Chewable Tablet [Gaviscon Chewable]
- RxCUI: 1086458 - Gaviscon Chewable 80/14.2 (aluminum hydroxide / magnesium trisilicate) Chewable Tablet
- RxCUI: 1086458 - Gaviscon Chewable 80/14.2 Chewable Tablet
- RxCUI: 1086458 - Gavsicon Regular Strength (aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG) Chewable Tablet
Which are the Pharmacologic Classes for Gaviscon Regular Strength?
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".